Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria

Journal of Clinical Microbiology

Volumn 50, Issue 10, 2012, Pages 3398-3401

  Lee, Meng Rui ^a   Cheng, Aristine ^b,c   Huang, Yu Tsung ^b,c   Liu, Chia Ying ^b   Chung, Kuei Pin ^c   Wang, Hao Chien ^c   Liang, Sheng Kai ^c   Liao, Chun Hsing ^b   Yu, Chong Jen ^c   Hsueh, Po Ren ^c  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERNAL TRANSCRIBED SPACER; RIFAMPICIN; RNA 16S;

ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATION; CONTROLLED STUDY; DIAGNOSTIC KIT; GENE AMPLIFICATION; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM ASCIATICUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM LENTIFLAVUM; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM SHIMODEI; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM XENOPEI; NONHUMAN; PRIORITY JOURNAL; RPOB GENE;

ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM TUBERCULOSIS; NONTUBERCULOUS MYCOBACTERIA; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 84866455746     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01862-12     Document Type: Article

References (21)

1. Adékambi T. 2009. Mycobacterium mucogenicum group infections: a review. Clin. Microbiol. Infect. 15:911-918.
2. Bastian S, et al. 2011. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrlsequencing. Antimicrob. Agents Chemother. 55:775-781.
3. Chen C, Lai HWCC, Tan CK. 2009. Arthritis caused by Mycobacteriumterrae in a patient with rheumatoid arthritis. Int. J. Infect. Dis. 13:e145-e147.
4. Duarte RS, et al. 2009. Epidemic of postsurgical infections caused by Mycobacterium massiliense. J. Clin. Microbiol. 47:2149-2155.
5. Griffith DE, et al. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367-416.
6. Kim HY, et al. 2010. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns. Microbiol. Immunol. 54:347-353.
7. Koh WJ, et al. 2011. Clinical significance of differentiation of Mycobacteriummassiliense from Mycobacterium abscessus. Am. J. Respir. Crit. Care Med. 183:405-410.
8. Lai CC, Wang HC. 2011. Clinical significance of Mycobacterium abscessusisolates at a medical center in Northern Taiwan. J. Microbiol. Immunol. Infect. 44:488-489.
9. Lai CC, et al. 2008. Fatal meningitis caused by Mycobacterium nonchromogenicumin a patient with nasopharyngeal carcinoma. Clin. Infect. Dis. 46:325-326.
10. Leao SC, Tortoli E, Euzeby JP, Garcia MJ. 2011. Proposal that Mycobacteriummassiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacteriumabscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus. Int. J. Syst. Evol. Microbiol. 61(Pt 9): 2311-2313.
11. Lee AS, Jelfs P, Sintchenko V, Gilbert GL. 2009. Identification of nontuberculous mycobacteria: utility of the GenoType Mycobacterium CM/AS assay compared with HPLC and 16S rRNA gene sequencing. J. Med. Microbiol. 58:900 -904.
12. Lee MR, et al. 2012. CNS infections caused by Mycobacterium abscessuscomplex: clinical features and antimicrobial susceptibilities of isolates. J. Antimicrob. Chemother. 67:222-225.
13. Lee MR, et al. 2012. Risk factors for Mycobacterium chelonae- abscessuspulmonary disease persistence and deterioration. J. Infect. 64:228-230.
14. Lindeboom JA, Bruijnesteijn van Coppenraet LE, van Soolingen D, Prins JM, Kuijper EJ. 2011. Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin. Microbiol. Rev. 24:701-717.
15. Liu YC, et al. 2011. Differential diagnosis of tuberculous and malignant pleurisy using pleural fluid adenosine deaminase and interferon gamma in Taiwan. J. Microbiol. Immunol. Infect. 44:88-94.
16. Nash KA, Brown-Elliott BA, and Wallace RJ, Jr. 2009. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacteriumabscessus but is absent from Mycobacterium chelonae. Antimicrob. Agents Chemother. 53:1367-1376.
17. Roth A, et al. 1998. Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. J. Clin. Microbiol. 36:139-147. (Pubitemid 28047449)
18. Shu CC, Wang JT, Wang JY, Yu CJ, Lee LN. 2012. Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacteriumtuberculosis. Clin. Microbiol. Infect. 18:246-258.
19. Turenne CY, Tschetter L, Wolfe J, Kabani A. 2001. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J. Clin. Microbiol. 39:3637-3648. (Pubitemid 32954514)
20. Wang JY, et al. 2004. Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacteriumtuberculosis in clinical specimens. J. Clin. Microbiol. 42:4599-4603.
21. Wu TL, et al. 2008. Rapid identification of mycobacteria from smear-positive sputum samples by nested PCR-restriction fragment length polymorphism analysis. J. Clin. Microbiol. 46:3591-3594.